Last ¥261.00 JPY
Change Today 0.00 / 0.00%
Volume 11.0K
4512 On Other Exchanges
Symbol
Exchange
Tokyo
As of 1:00 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for wakamoto pharm co ltd (4512)

Year over year, Wakamoto Pharmaceutical Co., Ltd. has seen revenues remain relatively flat (¥9.7B JPY to ¥9.4B JPY), though the company was able to grow net income from a loss of ¥425.0M JPY to a smaller loss of ¥222.0M JPY. A reduction in the percentage of sales devoted to cost of goods sold from 46.47% to 46.14% was a key component in the bottom line growth in the face of flat revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2009
Restated
JPY
Mar 31
2010
JPY
Mar 31
2011
JPY
Mar 31
2012
JPY
4 Year
Trend
Revenues10,080.39,776.79,669.09,432.0
TOTAL REVENUES10,080.39,776.79,669.09,432.0
Cost of Goods Sold3,853.34,096.64,493.04,352.0
GROSS PROFIT6,227.05,680.15,176.05,080.0
Selling General & Admin Expenses, Total4,969.34,778.24,884.04,744.0
R&D Expenses1,005.5875.0997.0792.0
Depreciation & Amortization, Total49.752.851.044.0
Other Operating Expenses-1.0-3.0----
OTHER OPERATING EXPENSES, TOTAL6,023.45,702.95,932.05,580.0
OPERATING INCOME203.5-22.9-756.0-500.0
Interest Expense---19.0-27.0-28.0
Interest and Investment Income57.334.733.034.0
NET INTEREST EXPENSE57.315.66.06.0
Other Non-Operating Income (Expenses)342.8176.5191.0258.0
EBT, EXCLUDING UNUSUAL ITEMS603.6169.2-559.0-236.0
Merger & Restructuring Charges---38.0----
Gain (Loss) on Sale of Investments---3.3-34.0-24.0
Gain (Loss) on Sale of Assets-----9.0125.0
Other Unusual Items, Total3.713.1-24.07.0
Insurance Settlements--22.9----
Other Unusual Items13.2--0.020.0
EBT, INCLUDING UNUSUAL ITEMS607.4141.0-626.0-128.0
Income Tax Expense256.092.5-201.094.0
Earnings from Continuing Operations351.448.5-425.0-222.0
NET INCOME351.448.5-425.0-222.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS351.448.5-425.0-222.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS351.448.5-425.0-222.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4512:JP ¥261.00 JPY 0.00

4512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4512.
View Industry Companies
 

Industry Analysis

4512

Industry Average

Valuation 4512 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WAKAMOTO PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.